{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:27:25Z","timestamp":1756463245605,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s13365-019-00820-4","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T16:03:11Z","timestamp":1576771391000},"page":"433-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Varicella zoster virus (VZV) oculomeningoencephalomyeloradiculitis: a previously undescribed constellation"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-5938","authenticated-orcid":false,"given":"Etsegenet F.","family":"Tizazu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"issue":"2","key":"820_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091017","volume":"142","author":"BL Burke","year":"1982","unstructured":"Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ (1982) Immune responses to varicella-zoster in the aged. Arch Intern Med 142(2):291\u2013293","journal-title":"Arch Intern Med"},{"key":"820_CR2","unstructured":"Centers for Disease Control and Prevention (2018) Shingles surveillance. In: Shingles (Herpes Zoster). Available via https:\/\/www.cdc.gov\/shingles\/surveillance.html. Accessed 2 Mar 2019"},{"issue":"11","key":"820_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","volume":"159","author":"CM Hales","year":"2013","unstructured":"Hales CM, Harpaz R, Joesoef MR, Bialek SR (2013) Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 159(11):739\u2013745","journal-title":"Ann Intern Med"},{"issue":"4","key":"820_CR4","first-page":"142","volume":"4","author":"CD Kalogeropoulos","year":"2015","unstructured":"Kalogeropoulos CD, Bassukas ID, Moschos MM, Tabbara KF (2015) Eye and periocular skin involvement in herpes zoster infection. Medical Hypothesis, Discovery and Innovation in Ophthalmology 4(4):142\u2013156","journal-title":"Medical Hypothesis, Discovery and Innovation in Ophthalmology"},{"key":"820_CR5","first-page":"1","volume":"00","author":"S Kedar","year":"2018","unstructured":"Kedar S, Jayagopal LN, Berger JR (2018) Neurological and ophthalmological manifestations of varicella zoster virus. Journal of Neuro-ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 00:1\u201312","journal-title":"Journal of Neuro-ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society"},{"issue":"1438","key":"820_CR6","first-page":"64","volume":"129","author":"J Mitchell","year":"2016","unstructured":"Mitchell J, Baguley K, Balm M, Ranta A (2016) Cranial polyneuropathy caused by varicella zoster reactivation. The New Zealand Medical Journal 129(1438):64\u201365","journal-title":"The New Zealand Medical Journal"},{"issue":"3","key":"820_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/WCO.0000000000000092","volume":"27","author":"MA Nagel","year":"2014","unstructured":"Nagel MA, Gilden D (2014) Neurological complications of VZV reactivation. Curr Opin Neurol 27(3):356\u2013360","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"820_CR8","first-page":"2151","volume":"31","author":"HB Park","year":"2004","unstructured":"Park HB, Kim KC, Park JH, Kang TY, Lee HS, Kim TH, Jun JB, Bae SC, Yoo DH, Craft J, Jung S (2004) Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol 31(11):2151\u20132155","journal-title":"J Rheumatol"},{"key":"820_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.antiviral.2018.08.006","volume":"158","author":"C Rondaan","year":"2018","unstructured":"Rondaan C, de Joode AA, van Assen S, Bos NA, Westerhuis R, Westra J (2018) Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus. Antivir Res 158:206\u2013212","journal-title":"Antivir Res"},{"issue":"5","key":"820_CR10","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30(5):985\u2013992","journal-title":"J Rheumatol"},{"issue":"1","key":"820_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3341\/kjo.2006.20.1.76","volume":"20","author":"SY Shin","year":"2006","unstructured":"Shin SY, Lee JM (2006) A case of multiple cranial nerve palsies as the initial ophthalmic presentation of antiphospholipid syndrome. Korean J Ophthalmol 20(1):76\u201378","journal-title":"Korean J Ophthalmol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-019-00820-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:53:57Z","timestamp":1659099237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-019-00820-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s13365-019-00820-4","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Etsegenet Tizazu reports no conflicts of interest. Gina Chang reports no conflicts of interest. Dr. Joseph R. Berger reports grants from Biogen, during the conduct of the study and personal fees from Millennium\/Takeda, personal fees from Merck-Sharpe-Dohme, personal fees from Novartis, personal fees from Biogen, personal fees from Roche\/Genentech, and personal fees from Genzyme\/Sanofi. He serves on the Scientific Advisory Boards of Excision-Bio and Inhibikase.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}